Literature DB >> 34107742

Microvascular Disease and Incident Heart Failure Among Individuals With Type 2 Diabetes Mellitus.

Arnaud D Kaze1, Prasanna Santhanam2, Sebhat Erqou3, Rexford S Ahima2, Alain Bertoni4, Justin B Echouffo-Tcheugui2,5.   

Abstract

Background Microvascular disease (MVD) is a potential contributor to the pathogenesis of diabetes mellitus-related cardiac dysfunction. However, there is a paucity of data on the link between MVD and incident heart failure (HF) in type 2 diabetes mellitus. We examined the association of MVD with incident HF in adults with type 2 diabetes mellitus. Methods and Results A total of 4095 participants with type 2 diabetes mellitus and free of HF were assessed for diabetes mellitus-related MVD including nephropathy, retinopathy, or neuropathy at baseline in the Look AHEAD (Action for Health in Diabetes) study. Incident HF events were prospectively assessed and adjudicated using hospital and death records. Cox models were used to generate hazard ratios and 95% CIs for HF. Of 4095 participants, 34.8% (n=1424) had MVD, defined as the presence of ≥1 of nephropathy, retinopathy, or neuropathy at baseline. Over a median of 9.7 years, there were 117 HF events. After adjusting for relevant confounders, participants with MVD had a 2.5-fold higher risk of incident HF than those without MVD (hazard ratio, 2.54; 95% CI, 1.73-3.75). This association remained significant after additional adjustment for interval development of coronary artery disease (hazard ratio, 2.42; 95% CI, 1.64-3.57). The hazard ratios for HF by type of MVD were 2.22 (95% CI, 1.51-3.27), 1.30 (95% CI, 0.72-2.36), and 1.33 (95% CI, 0.86-2.07) for nephropathy, retinopathy, and neuropathy, respectively. CONCLUSIONS MVD is associated with an excess HF risk in individuals with type 2 diabetes mellitus after adjusting for other known risk factors. Our findings underscore the contribution of MVD to the development of diabetes mellitus-related HF. REGISTRATION: URL: https://www.clinicaltrials.gov; Unique identifier: NCT00017953.

Entities:  

Keywords:  heart failure; microvascular disease; type 2 diabetes mellitus

Year:  2021        PMID: 34107742     DOI: 10.1161/JAHA.120.018998

Source DB:  PubMed          Journal:  J Am Heart Assoc        ISSN: 2047-9980            Impact factor:   5.501


  6 in total

Review 1.  Metabolic, structural and biochemical changes in diabetes and the development of heart failure.

Authors:  Kim L Ho; Qutuba G Karwi; David Connolly; Simran Pherwani; Ezra B Ketema; John R Ussher; Gary D Lopaschuk
Journal:  Diabetologia       Date:  2022-01-07       Impact factor: 10.122

2.  Computational Analysis of Routine Biopsies Improves Diagnosis and Prediction of Cardiac Allograft Vasculopathy.

Authors:  Eliot G Peyster; Andrew Janowczyk; Abigail Swamidoss; Samhith Kethireddy; Michael D Feldman; Kenneth B Margulies
Journal:  Circulation       Date:  2022-04-11       Impact factor: 39.918

Review 3.  Mechanisms and clinical implications of endothelium-dependent vasomotor dysfunction in coronary microvasculature.

Authors:  Sharif A Sabe; Jun Feng; Frank W Sellke; M Ruhul Abid
Journal:  Am J Physiol Heart Circ Physiol       Date:  2022-03-25       Impact factor: 5.125

4.  Lifetime Major Discrimination Experiences Moderate the Impact of Depressive Symptoms on Chronic Conditions among Black Americans.

Authors:  Kia Skrine Jeffers; Quenette L Walton; Millicent N Robinson; Courtney S Thomas Tobin
Journal:  Healthcare (Basel)       Date:  2021-11-09

5.  Fragmented QRS on electrocardiography as a predictor for diastolic cardiac dysfunction in type 2 diabetes.

Authors:  Kunimasa Yagi; Teruhiko Imamura; Hayato Tada; Jianhui Liu; Yukiko Miyamoto; Azusa Ohbatake; Naoko Ito; Masataka Shikata; Asako Enkaku; Akiko Takikawa; Hisae Honoki; Shiho Fujisaka; Daisuke Chujo; Hideki Origasa; Koichiro Kinugawa; Kazuyuki Tobe
Journal:  J Diabetes Investig       Date:  2022-02-16       Impact factor: 3.681

6.  Alleviation of Myocardial Inflammation in Diabetic Rats by Flavonoid Extract of Helichrysum Arenarium and Its Effect on Damaged Myocardial Cells Induced by High Glucose.

Authors:  Huanyu Liu; Wei Lan
Journal:  Front Surg       Date:  2022-04-14
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.